Exact Mass: 432.0491

Exact Mass Matches: 432.0491

Found 20 metabolites which its exact mass value is equals to given mass value 432.0491, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

lamotrigine-2-N-glucuronide

3,5-diamino-2-[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]-6-(2,3-dichlorophenyl)-1,2lambda5,4-triazin-2-ylium

C15H16Cl2N5O6 (432.0478)

lamotrigine-2-N-glucuronide is a metabolite of lamotrigine. Lamotrigine, marketed in the US and most of Europe as Lamictal by GlaxoSmithKline, is an anticonvulsant drug used in the treatment of epilepsy and bipolar disorder. It is also used as an adjunct in treating depression, though this is considered off-label usage. For epilepsy, it is used to treat focal seizures, primary and secondary tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. (Wikipedia)

5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine

C18H20Cl4N4 (432.0442)

C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

Lamotrigine N2-glucuronide

Lamotrigine N2-Glucuronide 85

C15H16Cl2N5O6+ (432.0478)

Pamoic acid disodium

C23H14Na2O6 (432.0586)

Pamoic acid disodium is a potent GPR35 agonist with an EC50 value of 79 nM. Pamoic acid disodium induces GPR35 internalization and activates ERK1/2 with EC50 values of 22 nM and 65 nM, respectively. Pamoic acid disodium potently recruits β-arrestin2 to GPR35 and has an antinociceptive effect[1].

N-(5-chloro-2-oxo-3-indolyl)-2-thiophen-2-yl-4-quinolinecarbohydrazide

C22H13ClN4O2S (432.0448)

1-[[4-(6-Chloro-3-pyridinyl)phenyl]methyl]-5-(trifluoromethoxy)indole-2,3-dione

C21H12ClF3N2O3 (432.0489)

2-[(4,6-dioxo-5-phenyl-1,4,5,6-tetrahydropyrimidin-2-yl)sulfanyl]-N-(4-sulfamoylphenyl)acetamide

C18H16N4O5S2 (432.0562)

8-{(2E)-2-[(2Z)-2-bromo-3-phenylprop-2-en-1-ylidene]hydrazinyl}-6-hydroxy-7-(2-hydroxyethyl)-3-methyl-3,7-dihydro-2H-purin-2-one

C17H17BrN6O3 (432.0545)

(2S,3S,4S,5R)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16Cl2N5O6+ (432.0478)

5-Chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine

C18H20Cl4N4 (432.0442)

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

(1r,1'r,9's,12'r,13'r)-13'-hydroxy-18'-methyl-2',15'-dioxa-10',11'-dithia-16',18'-diazaspiro[cyclohexane-1,14'-pentacyclo[10.5.2.0¹,⁹.0³,⁸.0¹²,¹⁶]nonadecane]-3,3',5',7'-tetraene-2,17',19'-trione

C19H16N2O6S2 (432.045)

9-({9-hydroxy-7-oxofuro[3,2-g]chromen-4-yl}oxy)-4-methoxyfuro[3,2-g]chromen-7-one

C23H12O9 (432.0481)